Watts S W, Traub O, Webb R C
Department of Physiology, University of Michigan, Ann Arbor 48109-0622.
Clin Exp Hypertens. 1994 Nov;16(6):881-98. doi: 10.3109/10641969409078032.
We have tested the hypothesis that altered vascular reactivity, specifically the appearance of spontaneous and BayK 8644 (L-type voltage gated calcium channel agonist)-induced oscillations in the carotid artery and the sarcoplasmic reticulum Ca(2+)-ATPase inhibitor cyclopiazonic acid (CPA)-induced oscillations in the aorta from stroke-prone spontaneously hypertensive rats (SHRS), are dependent upon angiotensin II production early in life. SHRSP and normotensive Wistar-Kyoto (WKY) rats were treated from 6-10 weeks of age with vehicle, hydralazine/hydrochlorothiazide (used as a control for lowered blood pressure) or the angiotensin converting enzyme inhibitor ramipril (3 mg/kg/day). Systolic blood pressures were measured weekly in rats from 6 to 17 weeks of age. In SHRSP (at 17 weeks of age), ramipril-treatment but not hydralazine/hydrochlorothiazide attenuated the long term expression of elevated systolic blood pressure in adult SHRSP while blood pressures of all adult WKY rats were unaffected by any treatment. At 17 weeks, rats were killed and arteries removed for in vitro measurement of isometric contractile activity. Only the incidence of spontaneous oscillations (carotid artery) was affected by ramipril treatment; ramipril did not change the frequency of BayK 8644-induced oscillations in the artery or the frequency of CPA-induced oscillations in aorta from either SHRSP or WKY. These data indicate that while spontaneous oscillations in the carotid artery may be dependent on an angiotensin II-sensitive mechanism during development, agonist-induced oscillations (CPA and BayK 8644) appear not to be angiotensin II-dependent. Thus, not all of the contractile oscillations which appear in vascular smooth muscle from SHRSP are angiotensin II-dependent, suggesting that some of these vascular abnormalities may develop at a time separate from that in which increased blood pressure is firmly established and may not be associated with the for maintenance of elevated blood pressure.
血管反应性改变,特别是易中风自发性高血压大鼠(SHRS)颈动脉中自发出现以及由BayK 8644(L型电压门控钙通道激动剂)诱导的振荡,和主动脉中由肌浆网Ca(2+) -ATP酶抑制剂环匹阿尼酸(CPA)诱导的振荡,依赖于生命早期的血管紧张素II生成。将SHRSP和正常血压的Wistar - Kyoto(WKY)大鼠在6至10周龄时用赋形剂、肼屈嗪/氢氯噻嗪(用作血压降低的对照)或血管紧张素转换酶抑制剂雷米普利(3毫克/千克/天)进行处理。在6至17周龄的大鼠中每周测量收缩压。在SHRSP(17周龄时),雷米普利治疗而非肼屈嗪/氢氯噻嗪减弱了成年SHRSP收缩压升高的长期表达,而所有成年WKY大鼠的血压不受任何处理的影响。在17周时,处死大鼠并取出动脉用于体外测量等长收缩活性。只有雷米普利治疗影响了自发振荡的发生率(颈动脉);雷米普利并未改变SHRSP或WKY大鼠动脉中BayK 8644诱导的振荡频率或主动脉中CPA诱导的振荡频率。这些数据表明,虽然颈动脉中的自发振荡在发育过程中可能依赖于血管紧张素II敏感机制,但激动剂诱导的振荡(CPA和BayK 8644)似乎不依赖于血管紧张素II。因此,并非SHRSP血管平滑肌中出现的所有收缩振荡都依赖于血管紧张素II,这表明这些血管异常中的一些可能在血压升高牢固确立的时间之外发生,并且可能与维持高血压无关。